Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06150599 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06150599 · ClinicalTrials.gov record · last posted 2026-07-13

Sacral Neuromodulation for Chronic Pelvic Pain

Study acronym: SNM_CPP
StatusRecruiting
PhaseNot applicable
Started2026-01-27
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
Sacral neuromodulation (SNM) is a safe, effective, and minimally invasive FDA approved treatment for urinary and fecal incontinence, urinary frequency, urgency, and urinary retention. In this study we are assessing the effectiveness of sacral neuromodulation in women with suffering from chronic pelvic pain (CPP), through a single device implant procedure.

Amendment record 10 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 10 times since 2023-11-20; most recent amendment 2026-07-10. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2025-04-04
Status change Not Yet Recruiting→Recruitingv6
Trial Details
NCT Number NCT06150599
Lead Sponsor Corewell Health East
Conditions Chronic Pelvic Pain Syndrome
Enrollment 25 participants
Start Date 2026-01-27
Primary Completion 2028-04-01 (estimated)
Study Completion 2028-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-13